TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive Regulatory Approvals: Gardasil 9 approved, which covers five additional HPV types December 12, 2014